Ke Li
- Urology top 5%
- Urological Disorders and Treatments 6
- Immunology top 10%
- Molecular Medicine top 10%
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 6
-
- Total Knee Arthroplasty Outcomes 8
- Lipoproteins and Cardiovascular Health 4
-
- Prostate Cancer Treatment and Research 8
- Prostate Cancer Diagnosis and Treatment 5
-
- RNA modifications and cancer 4
-
- Virus-based gene therapy research 4
- Co-authors
- Jie SituJianguang QiuXin GaoDejuan WangYunhua MaoDandan DongMinhua LuHong Yang
- Cited by
- UrologyImmunologyMolecular Medicine
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ke Li
107 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Urology 121
- Immunology 340
- Molecular Medicine 70
- Complementary and alternative medicine 111
- Cancer Research 201
Countries citing papers authored by Ke Li
This map shows the geographic impact of Ke Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Li more than expected).
Fields of papers citing papers by Ke Li
This network shows the impact of papers produced by Ke Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Li. The network helps show where Ke Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 32 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 11 | |
| 16 | 2018 | 28 | |
| 17 | 2017 | 7 | |
| 18 | 2016 | 1 | |
| 19 | 2016 | 33 | |
| 20 | 2014 | 19 |
About Ke Li
Ke Li is a scholar working on Urology, Cancer Research and Surgery, having authored 117 papers that have together received 1.9k indexed citations. Recurring topics across this work include Total Knee Arthroplasty Outcomes (8 papers), Prostate Cancer Treatment and Research (8 papers), Urological Disorders and Treatments (6 papers), Cancer, Lipids, and Metabolism (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Lipoproteins and Cardiovascular Health (4 papers), RNA modifications and cancer (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Urology (121 citations), Immunology (340 citations) and Molecular Medicine (70 citations). Ke Li has collaborated with scholars based in China, United States and France. Frequent co-authors include Jie Situ, Jianguang Qiu, Xin Gao, Dejuan Wang, Yunhua Mao, Dandan Dong, Minhua Lu, Hong Yang, Wei Huang and Xinmei Lin. Their work appears in journals such as Nature, Advanced Materials and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.